This inventor holds 1 USPTO granted patent. Top assignees: Centre Hospitalier Universitaire De Clermont-Fd, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2025
Title: Fabrice Anizon: Innovator in Pain Treatment
Introduction
Fabrice Anizon is a notable inventor based in Aubière, France. He has made significant contributions to the field of therapeutics, particularly in the development of novel compounds for pain management. His work is characterized by a focus on innovative solutions that address critical health challenges.
Latest Patents
Fabrice Anizon holds a patent for "Pyridin-2(1H)one derivatives, their preparation and their use for the treatment of pain." This invention concerns novel pyridin-2(1H)one derivatives, detailing their preparation processes and therapeutic applications, especially as agents for treating and preventing pain. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Anizon has worked with esteemed organizations such as the National Institute of Health and Medical Research and Sigma Clermont. His experiences in these institutions have allowed him to refine his research skills and contribute to significant advancements in medical research.
Collaborations
Fabrice Anizon has collaborated with notable colleagues, including Alain Artola and Pascale Moreau. These partnerships have enriched his research endeavors and fostered a collaborative environment for innovation.
Conclusion
Fabrice Anizon's work exemplifies the spirit of innovation in the medical field, particularly in pain management. His contributions through patents and collaborations highlight his dedication to improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile